...
首页> 外文期刊>Journal of Neurology >Cyclin-dependent kinase 5 is associated with risk for Alzheimer’s disease in a Dutch population-based study
【24h】

Cyclin-dependent kinase 5 is associated with risk for Alzheimer’s disease in a Dutch population-based study

机译:在一项基于荷兰人群的研究中,细胞周期蛋白依赖性激酶5与阿尔茨海默氏病风险相关

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Although the role of the Cdk5 protein in Alzheimer’s disease (AD) is well recognized, there have been relatively few studies investigating genetic variants in the CDK5 gene in AD. In this study, we assessed the association between five previously described single nucleotide polymorphisms (SNPs) in the CDK5 gene and late onset AD by means of logistic regression and haplotype association analyses. Including all prevalent and incident AD cases, we found a significantly increased risk of AD for carriers of the GG genotype of SNP rs2069442 (OR = 1.79, 95 % CI 1.16–2.79, p = 0.001) in those without APOE*4. When limiting the analysis to incident cases without APOE*4, carriers of the GG genotype showed a 1.9-fold increased risk of AD (95 % CI 1.16–3.10, p = 0.003). Variations in the CDK5 gene can be described in 5 haplotype blocks. In our analysis, the haplotype tagged by the G allele of SNP rs2069442 was significantly associated with AD (p = 0.05). In conclusion, our study suggests that CDK5 may be associated with AD.
机译:尽管Cdk5蛋白在阿尔茨海默氏病(AD)中的作用已广为人知,但有关AD中CDK5基因遗传变异的研究相对较少。在这项研究中,我们通过逻辑回归和单倍型关联分析评估了CDK5基因中五个先前描述的单核苷酸多态性(SNP)与晚期AD的关联。包括所有流行和偶发的AD病例,我们发现在没有APOE * 4的情况下,SNP rs2069442 GG基因型携带者的AD风险显着增加(OR = 1.79,95%CI 1.16–2.79,p = 0.001)。当将分析仅限于没有APOE * 4的突发事件时,GG基因型携带者显示出AD风险增加1.9倍(95%CI 1.16–3.10,p = 0.003)。 CDK5基因的变异可以描述为5个单倍型模块。在我们的分析中,由SNP rs2069442的G等位基因标记的单倍型与AD显着相关(p = 0.05)。总之,我们的研究表明CDK5可能与AD相关。

著录项

  • 来源
    《Journal of Neurology》 |2008年第5期|655-662|共8页
  • 作者单位

    Genetic Epidemiology Unit Dept. of Epidemiology ampamp Biostatistics and Dept. of Clinical Genetics Erasmus Medical Center 2040 3000 CA Rotterdam The Netherlands;

    Genetic Epidemiology Unit Dept. of Epidemiology ampamp Biostatistics and Dept. of Clinical Genetics Erasmus Medical Center 2040 3000 CA Rotterdam The Netherlands;

    Genetic Epidemiology Unit Dept. of Epidemiology ampamp Biostatistics and Dept. of Clinical Genetics Erasmus Medical Center 2040 3000 CA Rotterdam The Netherlands;

    Genetic Epidemiology Unit Dept. of Epidemiology ampamp Biostatistics and Dept. of Clinical Genetics Erasmus Medical Center 2040 3000 CA Rotterdam The Netherlands;

    Neurodegenerative Brain Diseases Group Dept. of Molecular Genetics VIB Antwerpen Belgium;

    Genetic Epidemiology Unit Dept. of Epidemiology ampamp Biostatistics and Dept. of Clinical Genetics Erasmus Medical Center 2040 3000 CA Rotterdam The Netherlands;

    Neurodegenerative Brain Diseases Group Dept. of Molecular Genetics VIB Antwerpen Belgium;

    Genetic Epidemiology Unit Dept. of Epidemiology ampamp Biostatistics and Dept. of Clinical Genetics Erasmus Medical Center 2040 3000 CA Rotterdam The Netherlands;

    Genetic Epidemiology Unit Dept. of Epidemiology ampamp Biostatistics and Dept. of Clinical Genetics Erasmus Medical Center 2040 3000 CA Rotterdam The Netherlands;

    Genetic Epidemiology Unit Dept. of Epidemiology ampamp Biostatistics and Dept. of Clinical Genetics Erasmus Medical Center 2040 3000 CA Rotterdam The Netherlands;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

    Alzheimer’s disease; Rotterdam Study; CDK5 gene; haplotype analysis;

    机译:阿尔茨海默氏病;鹿特丹研究;CDK5基因;单倍型分析;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号